Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)

PHASE3CompletedINTERVENTIONAL
Enrollment

547

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Allergic Rhinitis
Interventions
DRUG

BDP Nasal Aerosol

DRUG

Placebo

Trial Locations (63)

Unknown

Teva Investigational Site 10522, Hot Springs

Teva Investigational Site 10518, Costa Mesa

Teva Investigational Site 10526, Downey

Teva Investigational Site 10496, Huntington Beach

Teva Investigational Site 10536, Huntington Beach

Teva Investigational Site 10479, Mission Viejo

Teva Investigational Site 10524, Orange

Teva Investigational Site 10508, Paramount

Teva Investigational Site 10495, San Diego

Teva Investigational Site 10504, San Diego

Teva Investigational Site 10505, Stockton

Teva Investigational Site 10514, Centennial

Teva Investigational Site 10503, Colorado Springs

Teva Investigational Site 10499, Lawrenceville

Teva Investigational Site 10474, Savannah

Teva Investigational Site 10490, Stockbridge

Teva Investigational Site 10498, Stockbridge

Teva Investigational Site 10509, DeKalb

Teva Investigational Site 10493, Normal

Teva Investigational Site 10486, Indianapolis

Teva Investigational Site 10494, Louisville

Teva Investigational Site 10515, North Dartmouth

Teva Investigational Site 10540, Traverse City

Teva Investigational Site 10513, Columbia

Teva Investigational Site 10532, Missoula

Teva Investigational Site 10507, Brick

Teva Investigational Site 10534, Corning

Teva Investigational Site 10492, Cortland

Teva Investigational Site 10517, Niagara Falls

Teva Investigational Site 10482, Rochester

Teva Investigational Site 10535, Watertown

Teva Investigational Site 10478, High Point

Teva Investigational Site 10516, Holly Springs

Teva Investigational Site 10485, Canton

Teva Investigational Site 10480, Cincinnati

Teva Investigational Site 10500, Cleveland

Teva Investigational Site 10529, Middleburg Heights

Teva Investigational Site 10537, Ashland

Teva Investigational Site 10527, Medford

Teva Investigational Site 10502, Portland

Teva Investigational Site 10477, Blue Bell

Teva Investigational Site 10484, Upland

Teva Investigational Site 10511, Warwick

Teva Investigational Site 10497, Charleston

Teva Investigational Site 10521, Orangeburg

Teva Investigational Site 10528, Knoxville

Teva Investigational Site 10483, Boerne

Teva Investigational Site 10489, Dallas

Teva Investigational Site 10520, Dallas

Teva Investigational Site 10476, El Paso

Teva Investigational Site 10491, Kerrville

Teva Investigational Site 10487, Plano

Teva Investigational Site 10501, Plano

Teva Investigational Site 10523, San Antonio

Teva Investigational Site 10531, San Antonio

Teva Investigational Site 10539, San Antonio

Teva Investigational Site 10475, Waco

Teva Investigational Site 10488, Salt Lake City

Teva Investigational Site 10506, Salt Lake City

Teva Investigational Site 10510, Salt Lake City

Teva Investigational Site 10519, Burke

Teva Investigational Site 10481, Richmond

Teva Investigational Site 10533, Richmond

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT01783548 - Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR) | Biotech Hunter | Biotech Hunter